Biocon, Celgene settle patent litigation over cancer drug Revlimid Ruchika Sharma9 Sept 2021 2:58 PM ISTNew Delhi: Biotechnology major Biocon on Wednesday said it has entered into a settlement with Celgene Corporation regarding patents for Revlimid, a...
Sun Pharma settles patent dispute with Celgene over generic Revlimid Ruchika Sharma22 Jun 2021 12:24 PM ISTMumbai: Sun Pharmaceutical Industries Limited along with one of its wholly owned subsidiaries today announced that they have reached an agreement...
Cadila Healthcare Settles Patent Litigation for Generic Revlimid in US Medical Dialogues Team25 March 2021 5:15 PM ISTNew Delhi: Drugmaker Cadila Healthcare Limited and its subsidiary Zydus Pharmaceuticals (USA) Inc. (Zydus Cadila) have recently announced that they...
Cipla Settles Patent Litigation over REVLIMID Capsules with Celgene, Bristol Myers in US Ruchika Sharma12 Dec 2020 4:36 PM ISTAs part of the settlement, the Parties will file Consent Judgments with the United States District Court for the District of New Jersey that enjoin...
USFDA delays decision on Bristol Myers cancer therapy due to COVID-19 travel curbs Ruchika Sharma18 Nov 2020 9:00 AM ISTNew Delhi: Bristol Myers Squibb said on Monday the U.S. health regulator has deferred a decision on an experimental blood cancer therapy that it...
Bristol Myers Squibb posts better than expected Q3 earnings Ruchika Sharma7 Nov 2020 12:09 PM ISTNew Delhi: Bristol Myers Squibb Co on Thursday posted better-than-expected third-quarter earnings, with most of its top-selling drugs outperforming...
Dr Reddys settles patent litigation over cancer drug Revlimid with Celgene in US Ruchika Sharma19 Sept 2020 9:45 AM ISTRevlimid is used to treat multiple myeloma and myelodysplastic syndromes.
Natco Pharma, Celgene ink pact for cancer treatment drug Lenalidomide Ruchika Sharma11 July 2020 12:47 PM ISTLenalidomide is used to treat various types of cancers.
Natco settles patent litigation with Celgene on cancer drug savita thakur thakur24 Dec 2015 11:49 AM ISTNew Delhi: Natco Pharma and its US partner Allergan have settled a pending litigation with biopharmaceutical firm Celgene regarding generic...
